PillHydrocodone Bitartrate And Homatropine Methylbromide
Brands: Hydromet · Homatropine Methylbromide + Hydrocodone Bitartrate
2 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it2 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| PAI Holdings, LLC dba PAI Pharma | unknown | 1 | SUPPLYING |
| Genus Lifesciences | unknown | 1 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 1 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 11, 2025RESOLVEDShortage resolved: Homatropine Methylbromide and Hydrocodone Bitartrate Syrup (Teva Pharmaceuticals USA, Inc.)
Homatropine Methylbromide and Hydrocodone Bitartrate Syrup — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction.
- Sep 11, 2025SHORTAGEDrug shortage: Homatropine Methylbromide and Hydrocodone Bitartrate Syrup (Teva Pharmaceuticals USA, Inc.)
Homatropine Methylbromide and Hydrocodone Bitartrate Syrup — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction.